to BioTechniques free email alert service to receive content updates.
Single step BP/LR combined Gateway reactions
 
Xiquan Liang, Lansha Peng, Chang-Ho Baek, and Federico Katzen
Life Technologies, Carlsbad, CA
BioTechniques, Vol. 55, No. 5, November 2013, pp. 265–268
Full Text (PDF)
Supplementary Material
Abstract

The Gateway recombination system is characterized by its ability to transfer DNA sequences back and forth between an intermediate clone (the entry clone) and a variety of destination vectors. However, a number of applications do not need to exploit the advantages offered by the entry clone. Here we report reaction conditions for cloning DNA fragments into destination vectors in a single step reaction, thus reducing the cost and overall time needed to obtain an expression clone from three days to one.

The Gateway cloning system exploits the site-specific recombination system utilized by bacteriophage lambda to shuttle sequences between plasmids bearing flanking compatible recombination attachment (att) sites (1). Once captured as an entry clone, a DNA fragment can be recombined into a variety of destination vectors resulting in expression clones geared to specific applications (Figure 1A). The recombination reactions are driven by two enzyme blends known by their commercial names: BP Clonase and LR Clonase (Figure 1B). Further details on the Gateway system can be found in an earlier review (2).

Method summary

We developed efficient, cost and time saving protocols that enable the isolation of Gateway entry and expression clones using a single consolidated reaction capable of simultaneously performing BP and LR recombination steps.




Figure 1.  (Click to enlarge)




One of the drawbacks of the system is that, starting from a linear PCR fragment, it takes two bacterial transformation steps (or three days) to obtain the final expression clone. For those applications that do not require the isolation of an entry clone, the workflow adds two days to the overall cloning timeframe compared with other cloning approaches.

Here we describe a new approach combining the two Gateway steps, BP and LR recombination, into a single reaction, thereby reducing the time needed to obtain a final expression clone from three days to one.

The rationale for our approach stems from the fact that the main difference between the BP and LR reactions is the presence of the lambda excisionase (Xis) in the LR Clonase blend, which drives the recombination dynamics toward phage excision (3). Therefore, there should be an excisionase level where both reactions occur at similar rate.

To facilitate the fine tuning of the BP/LR combined reaction, we employed a DNA fragment harboring the lacZα reporter gene. The linear double-stranded DNA fragment was used as delivered by a gene synthesis provider, without precloning or prior PCR amplification. Reactions were set up using different ratios of BP and LR Clonase in the presence of the reporter sequence as well as donor and destination vectors (see Supplementary Material). Successful recombination events into both vectors were represented as blue colonies selected on X-gal agar plates supplemented with the corresponding antibiotics.

The results showed that at elevated LR/BP ratios the product is enriched in the expression clone, whereas opposite proportions produce an enrichment of the entry clone (Figure 2A and 2B). The cloning efficiencies depicted in Figure 2A and 2B are based exclusively on the percentage of blue colonies, and therefore underestimate the real recombination efficiency. For example, DNA sequencing of four random kanamycin resistant white colonies revealed that all four contain the right insert with internal single nucleotide mutations, reflecting errors during DNA synthesis. On the other hand, the sequence of 10 random ampicillin resistant white colonies showed that half contained similar errors as above. Equivalent results were obtained when a PCR fragment encoding the GFP gene preceded by the tac promoter was used instead of the lacZα gene (Figure 2C and D), suggesting that the method is generally applicable.




Figure 2.  (Click to enlarge)




Overall our results showed that BP and LR recombination can proceed at high efficiencies in a single tube without the need for subsequent steps. If the exclusive goal is to obtain an expression clone, the use of LR Clonase alone is the preferred option, as it can perform both recombination events, producing thousands of expression clones. Under these conditions, when the excisionase protein is present, BP recombination operates at a lower rate and, as expected, a reduced number of entry clones are obtained. This number, although sufficiently large for most cases, may fluctuate depending on the nature and quality of the insert and vectors. Methods to further increase the chances of simultaneous entry clone selection include (i) using electroporation rather than chemical transformation protocols, or (ii) raising the BP:LR Clonase ratio to 1:3.

The strategy presented here could be expanded to cover the assembly of multiple fragments into a single vector as proposed previously (4). However, the isolation of individual entry clones should be subjected to screening as all of them will likely provide the same antibiotic resistance.

Finally, our approach can also be applied to transfer an insert from an expression clone to a second destination vector in a single step. In this case a linearization of the expression clone will be necessary to reduce the background, unless the antibiotic resistance markers of the two episomes are different. Author contributions

XL, CHB, and LP performed the experiments. FK conceived the idea and wrote the manuscript.

Competing interests

The authors hold financial interests in Life Technologies.

Correspondence
Address correspondence to Federico Katzen, Life Technologies, Carlsbad, CA. E-mail: [email protected]

References
1.) Hartley, J.L., G.F. Temple, and M.A. Brasch. 2000. DNA cloning using in vitro site-specific recombination. Genome Res. 10:1788-1795.

2.) Katzen, F. 2007. Gateway recombinational cloning: a biological operating system. Expert Opin Drug Discov. 2:571-589.

3.) Landy, A. 1989. Dynamic, structural, and regulatory aspects of lambda site-specific recombination. Annu. Rev. Biochem. 58:913-949.

4.) Cheo, D.L., S.A. Titus, D.R. Byrd, J.L. Hartley, G.F. Temple, and M.A. Brasch. 2004. Concerted assembly and cloning of multiple DNA segments using in vitro site-specific recombination: functional analysis of multi-segment expression clones. Genome Res. 14:2111-2120.